Fingerprint
Dive into the research topics of 'Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
Lecia V. Sequist, Jhanelle Elaine Gray, Wael A. Harb, Ariel Lopez-Chavez, Robert C. Doebele, Manuel R. Modiano, David Michael Jackman, Maria Quintos Baggstrom, Akin Atmaca, Enriqueta Felip, Mariano Provencio, Manuel Cobo, Bambang Adiwijaya, Geoffrey Kuesters, Walid S. Kamoun, Karen Andreas, J. Marc Pipas, Sergio Santillana, Byoung Chul Cho, Keunchil Park
Research output: Contribution to journal › Article › peer-review
35
Scopus
citations